Technology: biotechnology industry: corporate taxation.

This measure would declare the support of the Legislature for federal tax policies designed to encourage growth, incentivize corporations to remain in the United States, and reduce competitive disadvantages for companies based in the United States, particularly those in the biomedical and life sciences industry. The measure would further urge the President and Congress to enact specified tax strategies to encourage domestic economic growth.